Chemistry:Hexolame
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Other names | 17β-((6-Hydroxyhexyl)amino)estradiol; 17β-[(6-Hydroxyhexyl)amino]estra-1,3,5(10)-trien-3-ol; N-(3-Hydroxy-1,3,5(10)-estratrien 17-yl)-6-hydroxyhexylamine |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C24H37NO2 |
| Molar mass | 371.565 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Hexolame, also known as 17β-((6-hydroxyhexyl)amino)estradiol, is a synthetic, steroidal estrogen and a 17β-aminoestrogen with anticoagulant effects that was first described in 1990 and was never marketed.[1][2][3]
References
- ↑ Organic-chemical drugs and their synonyms: (an international survey). Wiley-VCH. 2001. p. 12610. ISBN 978-3-527-30247-5. https://books.google.com/books?id=1nBqAAAAMAAJ.
- ↑ "The anticoagulant effect of hexolame, N-(3-hydroxy-1,3,5(10)-estratrien-17 beta-yl)-6-hydroxyhexylamine, another amino-estrogen with prolonged anticoagulant effect". Steroids 55 (2): 83–86. February 1990. doi:10.1016/0039-128x(90)90030-f. PMID 2326832.
- ↑ "Comparison of the time course of anticoagulant and estrogenic effects of prolame, butolame, pentolame and hexolame, a homologous series of 17 beta-amino estrogens". Proceedings of the Western Pharmacology Society 36: 143–147. 1993. PMID 8378368.
 |  |
